Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 6
2005 3
2006 4
2007 4
2008 3
2009 3
2010 9
2011 5
2012 5
2013 4
2014 7
2015 7
2016 5
2017 4
2018 4
2019 1
2020 9
2021 1
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
The Prevalence, Incidence, and Risk Factors for HIV Among Female Sex Workers-A Cohort Being Prepared for a Phase IIb HIV Vaccine Trial in Dar es Salaam, Tanzania.
Faini D, Msafiri F, Munseri P, Bakari M, Lyamuya E, Sandström E, Biberfeld G, Nilsson C, Hanson C, Aboud S. Faini D, et al. Among authors: sandstrom e. J Acquir Immune Defic Syndr. 2022 Dec 15;91(5):439-448. doi: 10.1097/QAI.0000000000003097. Epub 2022 Sep 20. J Acquir Immune Defic Syndr. 2022. PMID: 36126184 Free PMC article.
Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses.
Yang H, Llano A, Cedeño S, von Delft A, Corcuera A, Gillespie GM, Knox A, Leneghan DB, Frater J, Stöhr W, Fidler S, Mothe B, Mak J, Brander C, Ternette N, Dorrell L; Research in Viral Eradication of Reservoirs (RIVER) trial study group. Yang H, et al. Cell Rep. 2021 May 11;35(6):109103. doi: 10.1016/j.celrep.2021.109103. Cell Rep. 2021. PMID: 33979627 Free article.
Frequent and Durable Anti-HIV Envelope VIV2 IgG Responses Induced by HIV-1 DNA Priming and HIV-MVA Boosting in Healthy Tanzanian Volunteers.
Joachim A, Msafiri F, Onkar S, Munseri P, Aboud S, Lyamuya EF, Bakari M, Billings E, Robb ML, Wahren B, Mhalu FS, Sandström E, Rao M, Nilsson C, Biberfeld G. Joachim A, et al. Among authors: sandstrom e. Vaccines (Basel). 2020 Nov 13;8(4):681. doi: 10.3390/vaccines8040681. Vaccines (Basel). 2020. PMID: 33202967 Free PMC article.
Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA with or without CN54rgp140/GLA-AF in Healthy African Volunteers.
Msafiri F, Joachim A, Held K, Nadai Y, Chissumba RM, Geldmacher C, Aboud S, Stöhr W, Viegas E, Kroidl A, Bakari M, Munseri PJ, Wahren B, Sandström E, Robb ML, McCormack S, Joseph S, Jani I, Ferrari G, Rao M, Biberfeld G, Lyamuya E, Nilsson C. Msafiri F, et al. Among authors: sandstrom e. Microorganisms. 2020 Nov 4;8(11):1722. doi: 10.3390/microorganisms8111722. Microorganisms. 2020. PMID: 33158007 Free PMC article.
Induction of Identical IgG HIV-1 Envelope Epitope Recognition Patterns After Initial HIVIS-DNA/MVA-CMDR Immunization and a Late MVA-CMDR Boost.
Joachim A, Ahmed MIM, Pollakis G, Rogers L, Hoffmann VS, Munseri P, Aboud S, Lyamuya EF, Bakari M, Robb ML, Wahren B, Sandstrom E, Nilsson C, Biberfeld G, Geldmacher C, Held K. Joachim A, et al. Among authors: sandstrom e. Front Immunol. 2020 Apr 28;11:719. doi: 10.3389/fimmu.2020.00719. eCollection 2020. Front Immunol. 2020. PMID: 32411138 Free PMC article. Clinical Trial.
87 results